A Global Voice on Hangover Science: Dr. Joris Verster Publishes New Paper on Alcohol, Inflammation, and Health

Category 1 (1)

SJP-001 | Metabolic Recovery | Healthspan & Longevity

January 10 2025 Scientific Paper

Sen-Jam Pharmaceutical is proud to celebrate the recent publication of an insightful new paper by Dr. Joris C. Verster, one of our esteemed scientific advisors and a world-renowned expert in alcohol hangover research. The paper, titled “Alcohol Hangover: Time for a Paradigm Shift,” was just released in the Global Journal of Addiction & Rehabilitation Medicine, and it calls for a fundamental rethinking of how society—and science—addresses the impact of hangovers on public health.

In this powerful editorial, Dr. Verster argues that the traditional perception of hangovers as merely a nuisance overlooks their real-world consequences: impaired cognitive performance, reduced workplace productivity, and increased risk of accidents. He emphasizes the biological underpinnings of hangovers, particularly the inflammatory response triggered by alcohol consumption—an area where Sen-Jam’s own research and drug development efforts are deeply focused. Dr. Verster’s call to action for science, regulators, and the public to take hangovers more seriously resonates strongly with our mission to transform how we treat everyday inflammation-driven conditions.

 

Dr. Verster brings tremendous depth and credibility to this conversation. He is the founder of the Alcohol Hangover Research Group (AHRG) and a leading academic at Utrecht University and Leiden University in the Netherlands, with over 200 peer-reviewed publications. His commitment to rigorous, evidence-based research continues to advance global understanding of how lifestyle choices intersect with inflammation and health—making him an invaluable member of the Sen-Jam advisory team.

🧠 Read the full paper here: Alcohol Hangover: Time for a Paradigm Shift

📣 As we pioneer the first FDA-approved therapeutic for hangover prevention with SJP-001, we’re proud to have Dr. Verster helping lead the charge.

LINK TO THIS PAPER: https://juniperpublishers.com/gjarm/pdf/GJARM.MS.ID.555721.pdf

Recent Posts
Group 1000001207 (1)

Behind the Breakthrough: Strategic Insights from Sen-Jam’s Executive Leade...

In March 2025, Sen-Jam Pharmaceutical hosted a pivotal webinar in collaboration with Destum Partners, a premier strategic advisory firm known for driving success in biotech partnerships, licensing, and M&A…
Group 1000001074

Sen-Jam Pharmaceutical: Revolutionizing Inflammatory Care with Proprietary PAIR ...

HUNTINGTON, N.Y., Jan. 13, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical is proud to announce a pivotal moment in its mission to transform the way the world heals by tackling inflammation at its source…
Top View Of Female Hands Holding Cup Of Hot Tea Original 2740162 Min 1 1

Sen-Jam Pharmaceutical Files Groundbreaking Patent for Novel Therapeutic Approac...

HUNTINGTON, N.Y., Jan. 9, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical, a leader in innovative anti-inflammatory care, today announced the submission of a new patent application that introduces…

Media Inquiry